Skip to content
healthcare.dev

Regadenoson

NDC 76329-3321, Regadenoson, injection, solution, from International Medication Systems, Limited.

Product NDC
76329-3321
Status
Listed
Labeler
International Medication Systems, Limited
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214252
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76329-3321 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REGADENOSON ANHYDROUS.08 mg/mL

Pharmacologic classes

Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]

Package NDCNDC-11Package
76329-3321-0763293321001 SYRINGE in 1 CARTON (76329-3321-0) / 5 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/288c76cc-ff3e-47ea-ae02-be566bd3e093

Use it

Look up 76329-3321 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76329-3321 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76329-3321. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.